Minrin (Desmopressin Acetate)

Desmopressin, the active ingredient in Minrin, is a vasopressin analog presented as an injectable solution for intramuscular, intravenous or subcutaneous use. It is employed to reduce excessive urine output and to support hemostasis in specific bleeding disorders. GNH USA supplies Minrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway and is indicated for several endocrine and haemostatic conditions.

Central diabetes insipidus: concentrates urine and lowers polyuria. Nocturnal enuresis: reduces nighttime bedwetting episodes in children and adolescents. Hemophilia A (adjunct): enhances clot stability by raising factor VIII levels. Von Willebrand disease: improves platelet adhesion and reduces bleeding tendency.

Desmopressin may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea or abdominal discomfort. - Facial flushing or warmth. - Hyponatraemia: mild reduction in serum sodium. - Mild hypotension: transient blood pressure drop. - Nasal congestion (if administered intranasally).

Serious or Rare Side Effects: - Severe hyponatraemia leading to seizures or coma. - Water intoxication with cerebral oedema. - Thrombotic events in patients with predisposition. - Allergic reactions including rash or anaphylaxis. - Hyponatraemic encephalopathy. - Cardiac arrhythmias secondary to electrolyte shifts.

Desmopressin requires careful monitoring in several clinical situations.

Renal function: assess and monitor in severe impairment. Electrolyte balance: check serum sodium regularly, especially in the elderly. Cardiovascular disease: use cautiously in patients with hypertension or heart failure. Concomitant diuretics: increase risk of hyponatraemia; monitor closely. Pregnancy and lactation: evaluate risk‑benefit before prescribing. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Desmopressin may interact with drugs that affect water balance or haemostasis.

Major Interactions (Avoid): - Carbamazepine: reduces desmopressin efficacy. - MAO inhibitors: heighten risk of hyponatraemia. - NSAIDs: may potentiate antidiuretic effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors: can enhance hypotensive response. - Thiazide diuretics: increase hyponatraemia risk. - SSRIs: monitor serum sodium for additive effect.